🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Italian Register of Actionable @Mutations (RATIONAL) published in Eur J Cancer. @ESCAT levels I-III actionable Fabio Gratton alterations in 45.8% @cancer patients Potentially germline genomic alterations in 11.2% 11.7% received Frank Neumann @biomarker doi.org/10.1016/j.ejca…

Our team meeting in person at #ASCO23 to progress our efforts for equity in precision oncology across the The Lancet Oncology commission programs #GlobalGoals #PrecisionMedicine

Come and visit our SIC Italian Cancer Society booth #45 at the #EACR2023 meeting in Turin to find out about the next #SIC_cancer24 conference. Look forward to more science talks, networking and opportunities on 25-27 September 2024 🔬🧬🧫

🔥How could you best kick-off #WCGIC2023? 👉Looking forward to an exciting PeerVoice Educational Event with my fantastic colleagues Angela Lamarca & Nicola Normanno 👉Modern Management of Cholangiocarcinoma: Sharing Evidence, Experience, and Expertise ESMO - Eur. Oncology Milca Malary EASL Education

Outstanding faculty and topic for kicking off this #WCGIC2023! Angela Lamarca Arndt Vogel Nicola Normanno

Nicola Normanno Clinical utility of ctDNA: current role and emerging applications #MSD #ECP23

Nicola Normanno at #ECPinDublin2023

🚨Event alert! 📢Community 365 Roundtable on Genomic Tumour Testing: Delivering Precision Goals in European Oncology🗓️ 3 October, 14:00 -17:30 CEST Contribute to a frank discussion led by Patrycja Rzadkowska & Mark Lawler and other experts. Register👉bit.ly/3K1GBf7

#SISMEC 2023 Comparison of different #TMB testing UniversitàVanvitelli Nicola Normanno Paolo Chiodini

Join Nicola Normanno (Director of Cell Biology & Biotherapy Unit at INT-Fondazione Pascal) and others at our pre-ESMO symposium on October 20. Register now: bit.ly/3PAqF5i. #Oncology #ESMO2023

🔥Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing Cancer Treatment Reviews doi.org/10.1016/j.ctrv… 👉Understand all the advantages & disadvantages of hybrid capture vs amplicon-based enrichment and DNA vs RNA based NGS ESMO - Eur. Oncology EASL Education

New! Although #GenomicTests can lead to better outcomes in #CancerCare by informing #CancerRisk, prognosis, and therapeutic selection, they remain underutilized in routine #CancerCare. Find practical guidance from authors at acsjournals.onlinelibrary.wiley.com/doi/full/10.33… OncoAlert Melissa B Davis, PhD

🇮🇹ERMES phase III trial explored de-escalation in first-line therapy for RAS/BRAF wt mCRC. Journal of Clinical Oncology Maintenance Cet showed a favorable safety profile with interesting OS, but it may not be universally recommended. ascopubs.org/doi/pdf/10.120… OncoAlert VJ Oncology ONcotwITting

Much to be learnt about liver tumor pathology at #LiverCancerSummit 2024! In the Plenary session, "Liver Tumors Pathology: From Tissues to Algorithms," chaired by Jessica Zucman-Rossi and Julien Calderaro, we talking about histopathology and prognostic biomarkers, followed by a

Dr. Nicola Normanno at #RomeLung24 shows the promise of #MRD in early stage driver positive NSCLC. Still need to identify the optimal platform and approach that maximizes both sensitivity and specificity and multi-gene assays may be needed.

EFPIA Incisive Health SANT Committee Press Cancer Patients Europe EU One Health EU Science & Innovation 🇪🇺 EUinmyRegion🇪🇺 European Committee of the Regions Serafino Nardi 🇪🇺 Diving into regional excellence w/ Dr Normanno, Scientific Director at IRST "Dino Amadori" IRCCS stressing importance of #PrecisionOncology: 👉 #Biomarkers testing is 🔑 to guide therapies 👉 Focus on hereditary genetic mutations 👉 But…Limited access (reimboursement)➡️Need to tackle it.

EFPIA Incisive Health SANT Committee Press Cancer Patients Europe EU One Health EU Science & Innovation 🇪🇺 EUinmyRegion🇪🇺 European Committee of the Regions Serafino Nardi 🇪🇺 IRST "Dino Amadori" IRCCS Nicola Normanno Birgitta Sacrédeus European Commission Michele Calabrò Can.Heal JANE EU JOINT ACTION Sciensano PCM4EU Cluster Imago-Mol Robert Fabregat ☮️🏳️‍🌈🏳️‍⚧️🟣🎗 Alina Capitanu Elisa Sangiorgi Regione Emilia-Romagna Wrapping up with a panel on 'Pathways to Access: Overcoming Financial Barriers in #PrecisionOncology' with insights from @HEcoPerMed, Cancer Patients Europe Europe, EFPIA /Novartis, and Regione Emilia-Romagna. Engaging discussion on barriers and how to achieve #equitableaccess! 💡🌍

🔥NatureRevClinOncol🆙 ✅Circulating tumour DNA in early stage and locally advanced NSCLC: ready for clinical implementation? 🎯Need for interventional studies to provide evidence 👥Nicola Normanno #LCSM OncoAlert #LiquidBiopsy #ctDNA nature.com/articles/s4157…

Grazie all’Istituto Oncologico Romagnolo per questo privilegio ⁦IEO⁩ ⁦Università degli Studi di Milano⁩ linkedin.com/posts/istituto…

A very productive and successful #CIOT25 in Venice with a little time to see the city with friends - mark your calendar for #CIOT26 on June 18-19 in Palermo, Sicily! OncoPolmoneIEO